← Browse by Condition
Medical Condition

smoking

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 4

ClinicalMetric tracks all active clinical trials for smoking sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — smoking Clinical Trials

How many clinical trials are currently recruiting for smoking?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for smoking, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for smoking?
smoking research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a smoking clinical trial?
Eligibility criteria for smoking trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
Washington University School of Medicine 1 trial
Uskudar University 1 trial
University of Virginia 1 trial
Eli Lilly and Company 1 trial
Oregon Health and Science University 1 trial

Recruiting Clinical Trials

NCT07166120
Recruiting
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
Enrollment
132 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT07312552
Recruiting
Association of Periodontal Status and Smoking With Salivary Inflammasome Markers
Enrollment
116 pts
Location
Turkey (Türkiye)
Sponsor
Uskudar University
View Trial →
NCT05660525
Recruiting
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
Enrollment
768 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT07223840 Phase 2
Recruiting
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Enrollment
222 pts
Location
United States, China...
Sponsor
Eli Lilly and Company
View Trial →
NCT04281979
Recruiting
Effects of a Specific Substance in Smokers
Enrollment
60 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
View Trial →
NCT06991062
Recruiting
Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHASE
Enrollment
100 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT04783857 Phase 4
Recruiting
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Enrollment
171 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT06561971
Recruiting
Effect of Different Centrifuge Values on Saliva High Sensitive C-Reactive Protein (Hs-CRP) Levels in Individuals With Different Smoking Amounts
Enrollment
90 pts
Location
Turkey (Türkiye)
Sponsor
Izmir Katip Celebi University
View Trial →
NCT07710820
Recruiting
A Multi-Site Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Cigarette Smokers
Enrollment
1,060 pts
Location
United States
Sponsor
RAI Services Company
View Trial →

Related Conditions

smoking cessation (3) smoking reduction (2) physician s role (1) periodontitis (1) periodontal disease (1) periodontal health (1) inflammasomes (1) smoking cigarette (1) smoking tobacco (1) quitting smoking (1) tobacco (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology